866-997-4948(US-Canada Toll Free)

Addiction Control Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Published By :

GlobalData

Published Date : Dec 2010

Category :

Therapeutic Area

No. of Pages : 57 Pages


GlobalData, the industry analysis specialist, has released its new report, “Addiction Control Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Addiction Control market. The report identifies the key trends shaping and driving the global Addiction Controlmarket. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Addiction Control sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. 

GlobalData estimated the addiction control market to be worth $4,206m in 2009, and forecast it to grow at 4.7% annually for the next eight years to reach $6,052m by 2017. The addiction control market has relatively high growth, as the market has relatively fewer treatment options so that physicians are not left with many options, which translates into a high prescription rate of existing branded and generic products. In addition, the successful launch of NicVAX which is currently in Phase III may significantly stimulate market growth in near future. The global addiction control market in 2009 primarily consisted of drug classes which included dopamaine and norepinephrine reuptake inhibitors and opoid receptor antagonists. However, the low treatment seeking rate and patent expiry of the current major marketed products such as Suboxone/Subutex, Campral, Nicotine replacement therapies (NRTs) and Zyban will act as a barrier to market growth. 

Scope

The report provides information on the key drivers and challenges of the Addiction Control market. Its scope includes:

  • Annualized global addiction control market revenues data from 2001 to 2009, forecast for seven years to 2017.
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as Dopamine and norepinephrine reuptake inhibitors, Dopamine receptor antagonists, Acetylcholinesterase inhibitors, Serotonin-norepinephrine reuptake inhibitors, vaccines eliciting anti-nicotine antibody production, Nicotinic Acetylcholine (nACh) Agonists, NK1 receptor antagonist and others.
  • Analysis of the current and future competition in the global Addiction Control market, covering key market players like Pfizer, Glaxosmithkline, Eli lilly and company, Alkermes, Merck, Nabi Biopharmaceuticals, Titan pharmaceuticals, H.Lundbeck, Celtic pharmaceuticals, Novartis and Cytos pharmaceuticals.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Addiction Control therapeutics market. 
Reasons to buy

The report will enhance your decision making capability. It will allow you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global Addiction Control market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Addiction Control market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What’s the next big thing in the global Addiction Control market landscape? - Identify, understand and capitalize.
Table of Content

1 Table of contents 3

1.1 List of Tables 5
1.2 List of Figures 5

2 Addiction Control Therapeutics: Introduction 6
2.1 Disease Overview 6
2.2 GlobalData Pipeline Report Guidance 8

3 Addiction Control Therapeutics: Market Characterization 9
3.1 Addiction Control Market Size 9
3.2 Addiction Control Market Forecast and CAGR 9
3.3 Drivers and Barriers for Addiction Control Market 11
3.3.1 Drivers for Addiction Control Market 11
3.3.2 Barriers for Addiction Control Market 11
3.4 Opportunity and Unmet Need 12
3.4.1 Opportunity and Unmet Need in the Nicotine Addiction Market, 2010 13
3.4.2 Opportunity and Unmet Need in the Substance Abuse Market, 2010 14
3.5 Key Takeaway 14

4 Addiction Control Therapeutics: Competitive Assessment 15
4.1 Overview 15
4.2 Strategic Competitor Assessment 15
4.3 Product Profile for the Major Marketed Products in Alcohol Dependence Market 16
4.3.1 Vivitrol (naltrexone) 16
4.3.2 Campral (acamprosate calcium) 17
4.3.3 Antabuse (disulfiram) 18
4.4 Product Profile for the Major Marketed Products in Nicotine Addiction Market 19
4.4.1 Chantix / Champix (varenicline) 19
4.4.2 Zyban (bupropion) 20
4.4.3 Nicotine Replacement Therapies 21
4.5 Product Profile for the Major Marketed Products in Drug Abuse Market 21
4.5.1 Suboxone /Subutex (naloxone+buprenorphine/buprenorphine) 21
4.5.2 Methadone 22
4.6 Key Takeaway 24

5 Addiction Control Therapeutics: Pipeline Assessment 25
5.1 Overview 25
5.2 Strategic Pipeline Assessment 25
5.2.1 Technology Trends Analytic Framework 25
5.2.2 Drug Abuse Therapeutics - Technology Trends Analytic Framework 26
5.2.3 Nicotine Addiction Therapeutics - Technology Trends Analytic Framework 28
5.2.4 Alcohol Addiction Therapeutics - Technology Trends Analytic Framewor 30
5.3 Addiction Control Therapeutics Promising Drugs under Clinical Development 32
5.4 Molecule Profile for Promising Drugs under Clinical Development for Drug Abuse 33
5.4.1 TA-CD 33
5.4.2 CPP-109 (Vigabatrin) 34
5.5 Molecule Profile for Promising Drugs under Clinical Development for Nicotine Addiction 35
5.5.1 NIC-VAX 35
5.5.2 TA-NIC 35
5.6 Molecule Profile for Promising Drugs under Clinical Development for Alcohol Dependence 36
5.6.1 Nalmefene 36
5.7 Addiction Control Therapeutics Pipeline Description 37
5.7.1 Drug Abuse Control Therapeutics Pipeline Description 37
5.7.2 Nicotine Addiction Control Therapeutics Pipeline Description 38
5.7.3 Alcohol Addiction Control Therapeutics Pipeline Description 39
5.8 Addiction Control Therapeutics Pipeline Portfolio 40
5.8.1 Addiction Control Therapeutics Regulatory and Phase III Pipeline 40
5.8.2 Addiction Control Therapeutics- Phase II Pipeline 41
5.8.3 Addiction Control Therapeutics-Phase I Pipeline 43
5.8.4 Addiction Control Therapeutics- Preclinical and Discovery Pipeline 44
5.9 Key Takeaway 44

6 Addiction Control Therapeutics: Implications for Future Market Competition 45
6.1 Drug Abuse Therapeutics Implications for Future Market Competition 45
6.2 Nicotine Addiction Therapeutics Implications for Future Market Competition 46
6.3 Alcohol Addiction Therapeutics Implications for Future Market Competition 47

7 Addiction Control Market: Future Players in Addiction Control Market 48
7.1 Introduction 48
7.2 Titan Pharmaceuticals 48
7.2.1 Overview 48
7.2.2 CNS Portfolio 49
7.3 Nabi Biopharmaceuticals 49
7.3.1 Overview 49
7.3.2 Financial Performance 49
7.3.3 CNS Portfolio 49
7.4 H. Lundbeck 50
7.4.1 Overview 50
7.4.2 CNS Portfolio 50
7.5 Nicobrand (Watson Pharmaceuticals) 51
7.5.1 Overview 51
7.5.2 CNS Portfolio 51

8 Addiction Control Market: Appendix 52
8.1 Market Definitions 52
8.2 Abbreviations 52
8.3 Research Methodology 52
8.3.1 Coverage 53
8.3.2 Secondary Research 53
8.3.3 Forecasting 53
8.3.4 Primary Research 56
8.3.5 Expert Panel Validation 56
8.4 Contact Us 56
8.5 Disclaimer 56
8.6 Sources 57

List of Table


Table 1: Addiction Control Therapeutics, Global, Market Forecast ($m), 20012009 9
Table 2: Addiction Control Therapeutics, Global, Market Forecast ($m), 20092017 10
Table 3: Major Marketed Products Comparison in Addiction Control Therapeutics Market, 2010 23
Table 4: Addiction Control Therapeutics, Most Promising Drugs Under Clinical Development, 2010 32
Table 5: Addiction Control Therapeutics, Drug Abuse - Regulatory and Phase III Pipeline, 2010 40
Table 6: Addiction Control Therapeutics, Nicotine Addiction - Regulatory and Phase III Pipeline, 2010 40
Table 7: Addiction Control Therapeutics, Alcohol Addiction - Regulatory and Phase III Pipeline, 2010 41
Table 8: Addiction Control Therapeutics, Drug Abuse - Phase II Pipeline, 2010 41
Table 9: Addiction Control Therapeutics, Nicotine Addiction - Phase II Pipeline, 2010 42
Table 10: Addiction Control Therapeutics, Alcohol Addiction - Phase II Pipeline, 2010 42
Table 11: Addiction Control Therapeutics, Drug Abuse - Phase I Pipeline, 2010 43
Table 12: Addiction Control Therapeutics, Nicotine Addiction - Phase I Pipeline, 2010 43
Table 13: Addiction Control Therapeutics, Alcohol Addiction - Phase I Pipeline, 2010 43
Table 14: Addiction Control Therapeutics, Drug Abuse - Preclinical and Discovery Pipeline, 2010 44
Table 15: Addiction Control Therapeutics, Alcohol Addiction - Preclinical and Discovery Pipeline, 2010 44
Table 16: Titan Pharmaceuticals, CNS Marketed Products, 2010 49
Table 17: Titan Pharmaceuticals, Pipeline Products, 2010 49
Table 18: Nabi Biopharmaceuticals, Pipeline Products, 2010 49
Table 19: H. Lundbeck, CNS Marketed Products, 2010 50
Table 20: H. Lundbeck, Pipeline Products, 2010 50
Table 21: Nicobrand, CNS Marketed Products, 2010 51
Table 22: Nicobrand, CNS Pipeline Products, 2010 51

List of Chart


Figure 1: Addiction Control Therapeutics, Global, Revenues ($m), 20012009 9
Figure 2: Addiction Control Therapeutics, Global, Market Forecast ($m), 20092017 10
Figure 3: Opportunity and Unmet Need in the Addiction Control Therapeutics Market 12
Figure 4: Opportunity and Unmet Need in the Nicotine Addiction Therapeutics, 2010 13
Figure 5: Opportunity and Unmet Need in the Substance Abuse Therapeutics, 2010 14
Figure 6: Strategic Competitor Assessment of the Major Marketed Products for Addiction Control, 2010 16
Figure 7: Technology Trends Analytic Framework of the Drug Abuse Therapeutics Pipeline, 2010 26
Figure 8: Technology Trends Analytic Framework of the Drug Abuse Therapeutics Pipeline, Discription, 2010 27
Figure 9: Technology Trends Analytic Framework of the Nicotine Addiction Therapeutics Pipeline, 2010 28
Figure 10: Technology Trends Analytic Framework of the Nicotine Addiction Therapeutics Pipeline, Description, November 2010 29
Figure 11: Technology Trends Analytic Framework of the Alcohol Addiction Therapeutics Pipeline, 2010 30
Figure 12: Technology Trends Analytic Framework of Alcohol Addiction Therapeutics Pipeline, Description, 2010 31
Figure 13: Drug Abuse Therapeutics, Pipeline by Mechanism of Action, 2010 37
Figure 14: Drug Abuse Therapeutics, Pipeline by Phase of Development, 2010 38
Figure 15: Nicotine Addiction Therapeutics, Pipeline by Mechanism of Action, 2010 38
Figure 16: Nicotine Abuse Therapeutics, Pipeline by Phase of Development, 2010 39
Figure 17: Alcohol Addiction Control Therapeutics, Pipeline by Mechanism of Action, 2010 39
Figure 18: Alcohol Addiction Control Therapeutics, Pipeline by Phase of Development, 2010 40
Figure 19: Implications for Future Market Competition in the Drug Abuse Therapeutics, 2010 45
Figure 20: Implications for Future Market Competition in the Nicotine Addiction Therapeutics, 2010 46
Figure 21: Implications for Future Market Competition in the Alcohol Addiction Therapeutics, 2010 47
Figure 22: Addiction Control Therapeutics Market, Clinical Pipeline by Company, 2010 48
Figure 23: GlobalData Market Forecasting Model 55

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *